Phase I trial of EC90 (keyhole-limpet hemocyanin fluorescein isothiocyanate conjugate) with GPI-0100 followed by EC 17 (folate- fluorescein isothiocyanate conjugate) in combination with interferon-alpha (ifnα) and interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 3081-3081
Author(s):  
T. Mohammad ◽  
R. J. Amato ◽  
J. Hernandez-McClain ◽  
R. Messman ◽  
D. Morgenstern ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Interferon Alpha ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Interleukin 2 ◽  
Fluorescein Isothiocyanate ◽  
Keyhole Limpet Hemocyanin

scholarly journals Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

2011 ◽  
Vol 30 (3) ◽  
pp. 1274-1275 ◽  
Author(s):  
Masashi Niwakawa ◽  
Katsuyoshi Hashine ◽  
Raizo Yamaguchi ◽  
Hirofumi Fujii ◽  
Yasuo Hamamoto ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Interferon Alpha ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Japanese Patients

Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

2006 ◽  
Vol 24 (4) ◽  
pp. 321-326 ◽  
Author(s):  
Thomas Olencki ◽  
Sareena Malhi ◽  
Tarek Mekhail ◽  
Robert Dreicer ◽  
Paul Elson ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Interleukin 2

Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

2011 ◽  
Vol 30 (3) ◽  
pp. 1046-1054 ◽  
Author(s):  
Masashi Niwakawa ◽  
Katsuyoshi Hashine ◽  
Raizo Yamaguchi ◽  
Hirofumi Fujii ◽  
Yasuo Hamamoto ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Interferon Alpha ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Japanese Patients

scholarly journals A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

2014 ◽  
Vol 37 (3) ◽  
pp. 180-186 ◽  
Author(s):  
Paul Monk ◽  
Elaine Lam ◽  
Amir Mortazavi ◽  
Kari Kendra ◽  
Gregory B. Lesinski ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Interleukin 2 ◽  
High Dose

scholarly journals Phase I Trial of Sequential Low-Dose 5-Aza-2′-Deoxycytidine Plus High-Dose Intravenous Bolus Interleukin-2 in Patients with Melanoma or Renal Cell Carcinoma

2006 ◽  
Vol 12 (15) ◽  
pp. 4619-4627 ◽  
Author(s):  
Jared A. Gollob ◽  
Catherine J. Sciambi ◽  
Bercedis L. Peterson ◽  
Tina Richmond ◽  
Monica Thoreson ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Low Dose ◽  
Interleukin 2 ◽  
High Dose ◽  
Intravenous Bolus
Sign in / Sign up

Export Citation Format

Share Document